Free Trial

Cipher Pharmaceuticals (CPH) Stock Forecast & Price Target

Cipher Pharmaceuticals logo
C$14.72 +0.07 (+0.48%)
(As of 11/20/2024 ET)

Cipher Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
3

Based on 4 Wall Street analysts who have issued ratings for Cipher Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Buy." Out of the 4 analysts, 1 has given a hold rating, 2 have given a buy rating, and 1 has given a strong buy rating for CPH.

Consensus Price Target

C$12.50
-15.08% Downside
According to the 4 analysts' twelve-month price targets for Cipher Pharmaceuticals, the average price target is C$12.50. The highest price target for CPH is C$17.00, while the lowest price target for CPH is C$8.00. The average price target represents a forecasted downside of -15.08% from the current price of C$14.72.
Get the Latest News and Ratings for CPH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cipher Pharmaceuticals and its competitors.

Sign Up

CPH Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$12.50C$12.50C$12.00N/A
Forecasted Upside-15.08% Downside-23.92% Downside-24.95% DownsideN/A
Consensus Rating
Buy
Buy
Buy
Buy

CPH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CPH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cipher Pharmaceuticals Stock vs. The Competition

TypeCipher PharmaceuticalsMedical Companies
Consensus Rating Score
3.00
2.80
Consensus RatingBuyModerate Buy
News Sentiment Rating
Negative News

See Recent CPH News
Neutral News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/11/2024Stifel Nicolaus
4 of 5 stars
 Lower TargetC$19.00 ➝ C$17.00+30.67%
9/13/2024Leede Financial
0 of 5 stars
D. Loe
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/12/2024Stifel Canada
0 of 5 stars
J. Keywood
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
2/14/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSpeculative Buy ➝ BuyC$4.75 ➝ C$8.00+13.96%
3/17/2023Leede Jones Gab
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Loe
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 08:53 AM ET.


CPH Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Cipher Pharmaceuticals is C$12.50, with a high forecast of C$17.00 and a low forecast of C$8.00.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cipher Pharmaceuticals in the last twelve months. There is currently 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CPH shares.

According to analysts, Cipher Pharmaceuticals's stock has a predicted downside of -15.08% based on their 12-month stock forecasts.

Over the previous 90 days, Cipher Pharmaceuticals's stock had 1 downgrade by analysts.

Cipher Pharmaceuticals has been rated by research analysts at Leede Financial, and Stifel Nicolaus in the past 90 days.

Analysts like Cipher Pharmaceuticals more than other "medical" companies. The consensus rating for Cipher Pharmaceuticals is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CPH compares to other companies.


This page (TSE:CPH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners